Skip to content
S8959Senate2023-2024 Session

Require Obesity Treatment Coverage

Official title

“Requires comprehensive coverage for treatment of obesity”

Sponsor Jeremy CooneySD-56Affects Health
Status
In Senate Committee
Health
Impact
8/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill requires all New York health insurance policies to provide comprehensive coverage for obesity treatment, including prevention, counseling, surgery, and FDA-approved medications.

Why it matters

  1. Reduces Barriers to Obesity Care. By requiring insurance to cover obesity treatment like any other medical condition, the bill removes financial and administrative hurdles that often prevent people from accessing effective obesity care, including expensive medications and surgeries.

  2. Expands Access to Latest Treatments. Insurers cannot impose restrictions on FDA-approved anti-obesity medications that are stricter than the official FDA labeling, ensuring patients have timely access to new and emerging therapies as soon as they’re approved for chronic weight management.

  3. Promotes Preventive and Holistic Approaches. Coverage is mandated not just for surgeries and medications, but also for prevention, nutrition counseling, and behavioral therapy, aligning insurance practices with modern, evidence-based approaches to treating obesity as a complex, chronic disease.

  4. Standardizes Information and Protections for Consumers. Insurers must proactively notify members about this expanded coverage, reducing confusion and empowering individuals to seek appropriate care without fear of hidden exclusions or surprise costs tied specifically to obesity.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Require Obesity Treatment Coverage

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Jeremy Cooney

Senator · Senate District 56

Chair, Procurement And ContractsChair, Transportation

No co-sponsors yet.

History

  1. Referred to health

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8959

IN SENATE

April 3, 2024

Introduced by Sen. COONEY -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the social services law and the insurance law, in relation to requiring comprehensive coverage for treatment of obesity

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision 2 of section 365-a of the social services law is amended by adding a new paragraph (nn) to read as follows:

(nn) (i) Comprehensive coverage for treatment of obesity, which shall include coverage for prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved antiobesity medication. For purposes of this paragraph, "FDA-approved antiobesity medication" shall mean any medication approved by the federal food and drug administration with an indication for chronic weight management in patients with obesity.

(ii) Coverage criteria for FDA-approved anti-obesity medications provided under this paragraph shall not be more restrictive than the FDA-approved indications for such treatments.

(iii) Coverage under this paragraph shall be neither different nor separate from coverage for any other illness, condition, or disorder for purposes of determining deductibles, lifetime dollar limits, copayment and coinsurance factors, and benefit year maximum for deductibles and copayment and coinsurance factors.

(iv) Nothing shall preclude the undertaking of utilization management to determine the medical necessity for treatment of obesity under this paragraph, provided that all such appropriateness and medical necessity determinations are made in the same manner as those determinations are made for the treatment of any other illness, condition, or disorder covered by such policy, contract, or plan.

(v) The department shall provide notice to eligible persons regarding the coverage required by this paragraph. The notice shall be in writing and shall be prominently positioned in any literature or correspondence sent to members and shall be transmitted to members within the calendar

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD11933-03-4

year when annual information is made available to eligible persons, or in any other mailing or communication to eligible persons.

§ 2. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 39 to read as follows:

(39) (A) Every policy which provides medical, major medical, or similar comprehensive-type coverage shall provide comprehensive coverage for treatment of obesity, which shall include coverage for prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medication. For purposes of this paragraph, "FDA-approved anti-obesity medication" shall mean any medication approved by the federal food and drug administration with an indication for chronic weight management in patients with obesity.

(B) Coverage criteria for FDA-approved anti-obesity medications provided under this paragraph shall not be more restrictive than the FDA-approved indications for those treatments.

(C) Coverage under this paragraph shall neither be different nor separate from coverage for any other illness, condition, or disorder for purposes of determining deductibles, lifetime dollar limits, copayment and coinsurance factors, and benefit year maximum for deductibles and copayment and coinsurance factors.

(D) Nothing shall preclude the undertaking of utilization management to determine the medical necessity for treatment of obesity under this paragraph, provided that all such appropriateness and medical necessity determinations are made in the same manner as those determinations are made for the treatment of any other illness, condition, or disorder covered by such policy, contract, or plan.

(E) The insurer shall provide notice to covered persons regarding the coverage required by this paragraph. The notice shall be in writing and shall be prominently positioned in any literature or correspondence sent to members and shall be transmitted to members within the calendar year when annual information is made available to covered persons, or in any other mailing or communication to covered persons.

§ 3. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 22 to read as follows:

(22) (A) Every insurer delivering a group or blanket policy for delivery in this state that provides medical, major medical, or similar comprehensive-type coverage shall provide comprehensive coverage for treatment of obesity, which shall include coverage for prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medication. For purposes of this paragraph, "FDA-approved anti-obesity medication" shall mean any medication approved by the federal food and drug administration with an indication for chronic weight management in patients with obesity.

(B) Coverage criteria for FDA-approved anti-obesity medications provided under this paragraph shall not be more restrictive than the FDA-approved indications for those treatments.

(C) Coverage under this paragraph shall neither be different nor separate from coverage for any other illness, condition, or disorder for purposes of determining deductibles, lifetime dollar limits, copayment and coinsurance factors, and benefit year maximum for deductibles and copayment and coinsurance factors.

(D) Nothing shall preclude the undertaking of utilization management to determine the medical necessity for treatment of obesity under this paragraph, provided that all such appropriateness and medical necessity determinations are made in the same manner as those determinations are made for the treatment of any other illness, condition, or disorder covered by such policy, contract, or plan.

(E) The insurer shall provide notice to covered persons regarding the coverage required by this paragraph. The notice shall be in writing and shall be prominently positioned in any literature or correspondence sent to members and shall be transmitted to members within the calendar year when annual information is made available to covered persons, or in any other mailing or communication to covered persons.

§ 4. Section 4303 of the insurance law is amended by adding a new subsection (vv) to read as follows:

(vv) (1) Every policy which provides medical, major medical, or similar comprehensive-type coverage shall provide comprehensive coverage for treatment of obesity, which shall include coverage for prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medication. For purposes of this subsection, "FDA-approved anti-obesity medication" shall mean any medication approved by the federal food and drug administration with an indication for chronic weight management in patients with obesity.

(2) Coverage criteria for FDA-approved anti-obesity medications provided under this subsection shall not be more restrictive than the FDA-approved indications for those treatments.

(3) Coverage under this subsection shall neither be different nor separate from coverage for any other illness, condition, or disorder for purposes of determining deductibles, lifetime dollar limits, copayment and coinsurance factors, and benefit year maximum for deductibles and copayment and coinsurance factors.

(4) Nothing shall preclude the undertaking of utilization management to determine the medical necessity for treatment of obesity under this subsection, provided that all such appropriateness and medical necessity determinations are made in the same manner as those determinations are made for the treatment of any other illness, condition, or disorder covered by such policy, contract, or plan.

(5) The insurer shall provide notice to covered persons regarding the coverage required by this subsection. The notice shall be in writing and shall be prominently positioned in any literature or correspondence sent to members and shall be transmitted to members within the calendar year when annual information is made available to covered persons, or in any other mailing or communication to covered persons.

§ 5. This act shall take effect on the one hundred eightieth day after it shall have become a law and shall apply to any policy issued, delivered, renewed, and/or modified on or after the effective date of this act.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the social services law and the insurance law, in relation to requiring comprehensive coverage for treatment of obesity

Purpose or general idea of bill

This legislation will expand access to services and medications to treat obesity.

Summary of provisions

Section 1 adds a new paragraph to subdivision (2) of section 365-a of the social services law, requiring state sponsored health plans to provide comprehensive coverage for the treatment of obesity.

Section 2 adds a new paragraph 39 to subsection (i) of section 3216 of the insurance law, requiring commercial insurance policies to provide comprehensive coverage for the treatment of obesity.

Section 3 adds a new paragraph 22 to subsection (1) of section 3221 of the insurance law, applying these same provisions to group or blanket policies that provide medical, major medical, or similar comprehensive- type coverage.

Section 4 adds a new subsection (vv) to section 4303 of the insurance law, applying these same provisions to group or blanket policies that provide medical, major medical, or similar comprehensive-type coverage.

Section 5 is the effective date.

Justification

The rate of obesity has reached epidemic proportions in New York State, affecting approximately 2 out of every 3 adult New Yorkers. According to the Centers for Disease Control and Prevention, obesity is a serious condition that increases the risk of chronic diseases such as heart disease, stroke, type 2 diabetes, some cancers, and even death. Addi- tionally, obesity is associated with substantial health care expendi- tures, costing New York's already overburdened healthcare system over $10 million annually.

Furthermore, disparities in obesity rates are significant across racial and ethnic groups, with its prevalence being highest among adults who are Black and Hispanic. These inequities underscore the need to address social determinants of health and remove barriers to comprehensive health care access.

Recent advances in understanding the underlying mechanisms of obesity and drug therapy to treat obesity have provided the medical community with additional safe and effective treatment options.

To improve overall health and lower the risk of secondary complications caused by obesity, it is critical that public policy ensure New Yorkers have access to these obesity treatment, intervention, and management options.

Prior legislative history

New bill.

Fiscal implications

To be determined.

Effective date

This act shall take effect one hundred eighty days after it shall have become law.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.